These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37909136)

  • 1. [Progress on mRNA vaccine for the prevention of major infectious diseases in humans and animals].
    Gao JQ; Zhao XJ; Hua JL
    Sheng Li Xue Bao; 2023 Oct; 75(5):647-658. PubMed ID: 37909136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
    Le T; Sun C; Chang J; Zhang G; Yin X
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in mRNA Vaccines for Infectious Diseases.
    Zhang C; Maruggi G; Shan H; Li J
    Front Immunol; 2019; 10():594. PubMed ID: 30972078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in mRNA vaccines.
    Li M; Wang Z; Xie C; Xia X
    Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current state of, prospects for, and obstacles to mRNA vaccine development.
    Aljabali AAA; Bashatwah RM; Obeid MA; Mishra V; Mishra Y; Serrano-Aroca Á; Lundstrom K; Tambuwala MM
    Drug Discov Today; 2023 Feb; 28(2):103458. PubMed ID: 36427779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [mRNA vaccines for infectious diseases: research progress and applications].
    Qin F; Ren N; Cheng W; Wei H
    Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):3966-3984. PubMed ID: 37877385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
    Maruggi G; Zhang C; Li J; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical progress and challenges of mRNA vaccines.
    Yu MZ; Wang NN; Zhu JQ; Lin YX
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1894. PubMed ID: 37096256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.
    Huang T; Peng L; Han Y; Wang D; He X; Wang J; Ou C
    Front Immunol; 2022; 13():922301. PubMed ID: 36090974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.
    Yang L; Tang L; Zhang M; Liu C
    Front Immunol; 2022; 13():896958. PubMed ID: 35928814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
    Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
    RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA-Based Vaccines Against Infectious Diseases.
    Alameh MG; Weissman D; Pardi N
    Curr Top Microbiol Immunol; 2022; 440():111-145. PubMed ID: 32300916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological effects of mRNA vaccines in malignant diseases.
    Heine A; Juranek S; Brossart P
    Mol Cancer; 2021 Mar; 20(1):52. PubMed ID: 33722265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited].
    Jawalagatti V; Kirthika P; Lee JH
    Front Immunol; 2022; 13():884862. PubMed ID: 35592330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives and Prospects on mRNA Vaccine Development for COVID-19.
    Jin L; Han Z; Zhao P; Sun K
    Curr Med Chem; 2022; 29(23):3991-3996. PubMed ID: 35170403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Advances on the Stability of mRNA Vaccines.
    Cheng F; Wang Y; Bai Y; Liang Z; Mao Q; Liu D; Wu X; Xu M
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines.
    Guo X; Liu D; Huang Y; Deng Y; Wang Y; Mao J; Zhou Y; Xiong Y; Gao X
    Virol J; 2023 Apr; 20(1):64. PubMed ID: 37029389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Considerations on the Development of mRNA Vaccines.
    Naik R; Peden K
    Curr Top Microbiol Immunol; 2022; 440():187-205. PubMed ID: 32638114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
    Lorentzen CL; Haanen JB; Met Ö; Svane IM
    Lancet Oncol; 2022 Oct; 23(10):e450-e458. PubMed ID: 36174631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.